Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR(-/-) and ApoE(-/-) mice. (Q46030126)
Jump to navigation
Jump to search
scientific article published on 8 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR(-/-) and ApoE(-/-) mice. |
scientific article published on 8 February 2012 |
Statements
1 reference
Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR(-/-) and ApoE(-/-) mice. (English)
1 reference
Sotirios Tsimikas
1 reference
Sung Kee Ryu
1 reference
Timothy J King
1 reference
Kazutoshi Fujioka
1 reference
Jennifer Pattison
1 reference
Fredrick J Pashkow
1 reference
8 February 2012
1 reference
1 reference
222
1 reference
1
1 reference
99-105
1 reference